NICEVILLE, Fla.--(BUSINESS WIRE)--Rod D. Martin, Managing Member of 10X Capital Management, LLC, the General Partner of 10X Fund, LP (“10X Fund”), the largest shareholder of Galectin Therapeutics Inc. (OTC: GALT), today issued the following statement:
